CVS|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.66 | - | - |
| Q2'26 | $1.87 | $2.58 | +38.0% |
| Q1'26 | $2.21 | $2.57 | +16.5% |
| Q4'25 | $1.00 | $1.09 | +8.8% |
| Q3'25 | $1.36 | $1.60 | +17.9% |
| Q2'25 | $1.46 | $1.81 | +23.9% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $104.3B | - | - |
| Q2'26 | $101.1B | $106.1B | +4.9% |
| Q1'26 | $95.0B | $100.4B | +5.7% |
| Q4'25 | $104.6B | $105.7B | +1.0% |
| Q3'25 | - | $102.9B | - |
| Q2'25 | - | $98.9B | - |
Market Data
CVS Stock Snapshot
CVS is currently trading at $95.52, giving CVS Health Corporation a market cap of 122.40B and a P/E ratio of 25.0. Today's range spans $94.57–$96.90, with shares opening at $95.20 and moving down $0.15 (0.2%) from the prior close. DailyIQ's technical score sits at 36/100 (HOLD) with a news sentiment reading of 84/100.
Over the past year CVS has traded between $62.55 and $110.68 - the current price is +52.7% off the 52-week low and -13.7% from the high. 35 analysts cover the stock with a Buy consensus and a mean 12-month target of $115.64 (range $103.00–$148.00), implying upside of +21.1%.
CVS Health Corporation (CVS) is a large-cap in Healthcare with 122.40B in market cap, currently sitting on a HOLD signal at 36/100. Price: $95.52 (in the upper portion of its 52-week range). Sentiment: bullish at 84/100. The current P/E ratio stands at 25.0. The 52-week range of $62.55–$110.68 is the structural anchor, and the current neutral phase is the market's way of asking for more information before committing to a direction.
Portfolio construction in Healthcare often uses large-cap names like CVS as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 36/100 (HOLD) at $95.52 (in the upper portion of its 52-week range) and bullish sentiment (84/100) frame the position as a catalyst play within the $62.55–$110.68 annual range rather than a directional bet.
Company Insights: CVS Health Corporation (CVS)
CVS Health Corporation operates as a diversified healthcare entity within the United States, offering a comprehensive suite of health solutions across its Healthcare Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The company's integrated model encompasses health insurance, pharmacy benefit management, and retail pharmacy operations, establishing it as a significant participant in the Healthcare Plans sector. This multifaceted approach allows CVS to serve a broad spectrum of consumer and employer needs within the healthcare ecosystem.
Recent financial performance indicates a positive trend in earnings per share (EPS) growth, with accelerating figures reported in recent quarters. While revenue has shown some variability, the consistent outperformance against analyst estimates highlights strong operational execution. This pattern of exceeding expectations suggests effective management and a resilient business model, even amidst a dynamic market environment.
However, the company faces notable headwinds, including significant regulatory challenges and strategic adjustments to its business lines. Recent news points to regulatory scrutiny in specific states and a planned scaling back of its Medicare Advantage business, alongside exiting the Obamacare marketplace. These developments necessitate careful monitoring as they could impact future growth trajectories and profitability.
Earnings Momentum
CVS has demonstrated accelerating EPS growth in recent reported quarters, indicating improving profitability.
The company has consistently beaten analyst EPS estimates, showcasing strong operational execution.
Revenue performance has shown some mixed trends, but the overall earnings beat rate is a positive indicator.
Integrated Model
CVS operates a diversified healthcare model spanning insurance, PBM services, and retail pharmacy.
This integrated approach allows for synergies across its various business segments.
The company's broad reach positions it as a key player in the U.S. healthcare landscape.
Regulatory Headwinds
Significant regulatory challenges are impacting specific state operations and business lines.
Strategic decisions include scaling back Medicare Advantage and exiting the Obamacare marketplace.
Navigating evolving regulatory landscapes and strategic adjustments will be critical for future performance.
Valuation Metrics
The current P/E ratio stands at 55.13, which may suggest a premium valuation relative to earnings.
The 52-week trading range indicates volatility, with the stock trading between $58.35 and $85.15.
Market capitalization is substantial at over $97 billion, reflecting its significant presence in the healthcare sector.
Positioning CVS
Investors considering CVS Health should weigh its consistent earnings beats and integrated business model against significant regulatory pressures and strategic shifts. Exposure might be warranted for those seeking exposure to a diversified healthcare player with a history of operational resilience. However, a cautious approach is advisable given the ongoing regulatory scrutiny and the company's strategic realignment in key insurance markets.
Key Metrics for CVS
CVS Health's integrated model, spanning insurance, pharmacy benefits, and retail, requires tracking key operational and financial health indicators. Investors should monitor these metrics to assess CVS's ability to navigate regulatory pressures and execute its strategic shifts.
Pharmacy Comp Sales: Measures sales growth at established CVS pharmacy locations, excluding new openings and closures. Stronger comparable sales indicate robust demand for prescription and front-store items, crucial for CVS's retail segment performance. This metric directly impacts revenue and profitability, reflecting consumer health needs and CVS's market penetration.
PBM Claims Processed: Tracks the volume of prescription claims managed by CVS's Pharmacy Benefit Management (PBM) services. An increasing number of claims signifies growth in its PBM business, a core revenue driver for CVS Health. This metric is vital for understanding the scale and reach of its health services segment and its ability to leverage its integrated model.
Health Benefits Membership: Represents the total number of individuals enrolled in CVS's health insurance plans. Growth in membership, particularly in profitable segments, is essential for the Healthcare Benefits segment's financial health. Declining membership, especially after strategic adjustments like scaling back Medicare Advantage, signals potential headwinds for CVS.
Operating Cash Flow: Indicates the cash generated from CVS's core business operations. A consistently growing or stable operating cash flow is vital for funding dividends, share buybacks, and strategic investments. This metric reflects the underlying financial strength and efficiency of CVS Health's diversified operations.
EPS Growth Rate: Measures the year-over-year percentage increase in CVS's earnings per share. Accelerating EPS growth suggests improved profitability and operational efficiency, which is positive for the stock. Fluctuations or deceleration in EPS growth can raise concerns about CVS's ability to manage costs and drive earnings in a complex healthcare environment.
What Moves CVS Stock?
CVS Health's stock performance is primarily driven by the operational results of its diversified healthcare segments, including pharmacy benefits, insurance, and retail pharmacy, alongside evolving regulatory landscapes and strategic business adjustments.
Segment Performance
CVS operates through distinct segments: Healthcare Benefits (insurance), Health Services (PBM), and Pharmacy & Consumer Wellness (retail). Each segment contributes uniquely to the company's overall financial health and growth trajectory.
Strong performance in any one segment, particularly the Pharmacy Benefit Management (PBM) services or the retail pharmacy operations, can offset weaker results elsewhere, influencing investor confidence and the stock's valuation.
Regulatory Environment
The healthcare industry is heavily regulated, impacting everything from insurance product offerings to pharmacy benefit management practices. Recent news highlights regulatory challenges, such as those in Tennessee, which can create uncertainty.
Adverse regulatory changes or increased scrutiny can lead to operational adjustments, reduced profitability, or even market exits (like scaling back Medicare Advantage), directly pressuring the stock price.
Strategic Adjustments
CVS is actively making strategic decisions, such as exiting the Obamacare marketplace in 2026 and focusing on profitable growth areas. The company is also exploring technological integrations, like using Google Cloud for its Health100 AI platform.
These strategic shifts aim to optimize the business model and enhance future earnings. Investor reaction to the perceived success or potential risks associated with these changes, including AI integration, will influence stock movement.
Key insight: CVS Health's stock is a barometer for its integrated healthcare model's execution amidst regulatory headwinds and strategic recalibrations. Investors closely monitor the interplay between its pharmacy, insurance, and PBM segments, as well as the company's ability to adapt to a dynamic regulatory environment and implement its forward-looking strategies.
Risk Factors
CVS Health faces risks primarily tied to regulatory changes, operational execution within its diverse segments, and the evolving healthcare landscape. Investors should monitor how these factors impact its integrated business model and profitability.
- Regulatory Scrutiny
CVS operates in a highly regulated industry, making it susceptible to changes in government policy and enforcement. New regulations, particularly concerning pharmacy benefit managers (PBMs) or healthcare benefits, could increase compliance costs or limit revenue streams. Such changes could materialize through legislative action or agency rulings, directly impacting profitability.
- PBM Competition
The pharmacy benefit management (PBM) segment faces increasing scrutiny and potential disruption from competitors and legislative bodies. Increased pricing pressure or unfavorable contract terms could erode margins within this crucial business segment. This risk could materialize if legislative changes mandate greater transparency or if competitors offer more aggressive pricing models.
- Medicare Advantage
CVS's decision to scale back its Medicare Advantage business and exit the Obamacare marketplace presents a strategic risk. A misstep in this transition or lower-than-expected performance in remaining plans could negatively affect revenue and earnings. This risk is most likely to materialize as these strategic shifts are implemented and their financial impact becomes apparent in future earnings reports.
- Integration Execution
The company's diversified model relies on seamless integration between its insurance, PBM, and retail pharmacy operations. Any failure in operational synergy or technology integration could lead to inefficiencies and impact customer experience. This risk could materialize if internal systems fail to communicate effectively or if strategic initiatives do not yield expected benefits.
- Healthcare Costs
Rising healthcare costs and inflation can put pressure on CVS's insurance and PBM segments. If medical cost trends accelerate beyond projections, it could lead to higher payouts for claims and reduced profitability. This risk is ongoing and would materialize if inflation continues to drive up healthcare service and drug prices.
Analyst Price Targets for CVS
Here's where sell-side analysts stand on CVS right now, based on the latest ratings DailyIQ has tracked.
Reflects the most recently tracked analyst ratings for CVS and may lag real-time updates. Not a recommendation to buy or sell.
CVS Recent Earnings History
- Q4 2025
EPS: $1.09 actual vs $1.0 estimate (beat) · Revenue: $105,693M actual vs $104,629M estimate
- Q3 2025
EPS: $1.6 actual vs $1.36 estimate (beat) · Revenue: $102,871M actual
- Q2 2025
EPS: $1.81 actual vs $1.46 estimate (beat) · Revenue: $98,915M actual
- Q1 2025
EPS: $2.25 actual vs $1.67 estimate (beat) · Revenue: $94,588M actual
- Q4 2024
EPS: $1.19 actual vs $0.92 estimate (beat) · Revenue: $97,710M actual
CVS Competitive Positioning
CVS Health Corporation (CVS) is tracked alongside these names in Healthcare Plans on DailyIQ.
Frequently Asked Questions About CVS
Is CVS Health Corporation (CVS) stock a good investment?
The investment thesis for CVS Health Corporation (CVS) centers on its integrated healthcare model, combining pharmacy, pharmacy benefit management (PBM), and health insurance. Its extensive retail footprint and growing PBM services offer a competitive advantage. Investors might consider its ability to navigate evolving healthcare regulations and its strategic focus on expanding into care delivery.
What drives CVS Health (CVS) stock price?
CVS Health's stock price is influenced by several factors, including the performance of its Pharmacy Benefit Management (PBM) segment, prescription volume, and the profitability of its retail pharmacy operations. Growth in its Aetna insurance business and the success of its strategic initiatives, like expanding primary care services, also play a significant role. Investor sentiment regarding healthcare policy and competition within the sector can also impact the stock.
Does CVS Health (CVS) pay a dividend?
Yes, CVS Health Corporation (CVS) typically pays a quarterly dividend to its shareholders. The company has a history of returning capital to investors through dividends, though the specific amount can be subject to change based on financial performance and strategic priorities. Investors should review the latest dividend announcements for current payout information.
What are the risks of investing in CVS Health (CVS)?
Risks associated with CVS Health (CVS) include intense competition in the pharmacy and insurance markets, potential regulatory changes impacting drug pricing and reimbursement, and challenges in integrating its diverse business segments. The company also faces operational risks related to its retail pharmacy network and the ongoing evolution of healthcare delivery models. Cybersecurity threats and litigation are also potential concerns.
How is CVS Health's valuation assessed?
CVS Health's valuation is often assessed using metrics such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value to EBITDA (EV/EBITDA). Investors compare these ratios to historical averages and to those of its peers in the healthcare and pharmacy sectors. The company's ability to generate consistent free cash flow and its growth prospects in areas like PBM and health services are key considerations for valuation.
What is CVS Health's strategy for growth?
CVS Health's growth strategy focuses on leveraging its integrated model to provide more comprehensive healthcare solutions. This includes expanding its PBM services, growing its retail pharmacy offerings with an emphasis on health and wellness products, and developing its Aetna insurance business. The company is also investing in new care delivery models and digital health initiatives to enhance patient engagement and outcomes.
How might regulatory changes affect CVS Health (CVS)?
Regulatory changes represent a significant factor for CVS Health (CVS). Policies affecting drug pricing, Medicare and Medicaid reimbursement rates, and the PBM industry could materially impact the company's profitability and revenue streams. Scrutiny over healthcare consolidation and market practices also poses a potential risk that investors closely monitor.
What is the outlook for CVS Health's Pharmacy Benefit Management (PBM) business?
The outlook for CVS Health's PBM business, Caremark, is generally viewed as a key driver of its performance. The segment benefits from scale and its integration with the company's retail pharmacy network. However, it faces ongoing scrutiny regarding its business practices and potential legislative changes that could affect its operating model and profitability.
How is CVS Health performing in its retail pharmacy segment?
CVS Health's retail pharmacy segment continues to be a cornerstone of its operations, offering prescription fulfillment and a wide range of consumer health products. Performance here is influenced by prescription volumes, generic dispensing rates, and competition from other retail pharmacies and mail-order services. The company is also exploring ways to enhance the health services offered within its retail locations.
What is the significance of CVS Health's acquisition of Aetna?
The acquisition of Aetna significantly transformed CVS Health by creating a vertically integrated healthcare company. This integration allows CVS to align its pharmacy benefit management, retail pharmacy, and health insurance capabilities, potentially leading to cost efficiencies and improved care coordination for members. The success of this integration is crucial for realizing the full strategic benefits.
Learn More
How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.
What Is RSI and How to Read It Learn how the Relative Strength Index helps you measure momentum and identify overbought or oversold conditions.
Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.
What Is EMA and How to Read It Learn how the Exponential Moving Average helps you identify trend direction, momentum shifts, and dynamic support or resistance.
Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.
Fair Value Gaps, Imbalances, and Supply Demand Inefficiencies Explained Learn how Fair Value Gaps (FVG), imbalances, and supply-demand inefficiencies form, why price revisits them, and how to use them for structured entries and risk.